Company Filing History:
Years Active: 1992
Title: Garth E Ziege: Innovator in Immunoassay Technology
Introduction
Garth E Ziege is a notable inventor based in Sheridan, IN (US). He has made significant contributions to the field of immunoassay technology, particularly with his innovative approach to measuring biologically active substances.
Latest Patents
Garth E Ziege holds a patent for a "Quantitative immunoassay system and method for agglutination assays." This advanced system is designed to accurately measure extremely low concentrations of various biologically active substances, ranging from 10.sup.-6 to 10.sup.-12 grams per milliliter. The system is highly sensitive and effective in detecting monoclonal or polyclonal antibodies, cancer markers, proteins, bacteria, viruses, therapeutic drugs, drugs of abuse, and contaminants in food and water. Notably, the system requires no sample preparation, making it reliable and easy to use in various settings, including doctors' offices and small labs.
Career Highlights
Garth E Ziege is associated with Seradyn, Inc., where he has applied his expertise in developing innovative immunoassay systems. His work emphasizes simplicity, accuracy, and extreme sensitivity, which are crucial for quantifying immunoassays effectively.
Collaborations
Some of Garth's coworkers include Patricia C Andrews and Andris Indriksons, who have likely contributed to the collaborative environment that fosters innovation at Seradyn, Inc.
Conclusion
Garth E Ziege's contributions to immunoassay technology exemplify the impact of innovative thinking in the medical field. His patented system represents a significant advancement in the accurate measurement of biologically active substances, enhancing diagnostic capabilities in various healthcare settings.